{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:03:31Z","timestamp":1756425811130,"version":"3.44.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,28]]},"DOI":"10.7759\/cureus.91158","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:53:49Z","timestamp":1756371229000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Acquired von Willebrand Syndrome in a Rare Case of Nodal Marginal Zone Lymphoma With Rituximab Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Gai","family":"Matsumura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19064","article-title":"Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology guideline","volume":"204","author":"Walewska R","year":"2024","unstructured":"Walewska R, Eyre TA, Barrington S, et al.. Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology guideline. Br J Haematol. 2024, 204:86-107. 10.1111\/bjh.19064","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler JE","year":"2006","unstructured":"Sadler JE, Budde U, Eikenboom JC, et al.. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006, 4:2103-14. 10.1111\/j.1538-7836.2006.02146.x","journal-title":"J Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20830","article-title":"Acquired von Willebrand syndrome: an update","volume":"82","author":"Franchini M","year":"2007","unstructured":"Franchini M, Lippi G. Acquired von Willebrand syndrome: an update. Am J Hematol. 2007, 82:368-75. 10.1002\/ajh.20830","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14648","article-title":"Acquired von Willebrand syndrome and lymphoid neoplasms: a review of malignancy management, and propositions of practical recommendations","volume":"28","author":"Nicol C","year":"2022","unstructured":"Nicol C, Pan-Petesch B, Ianotto JC. Acquired von Willebrand syndrome and lymphoid neoplasms: a review of malignancy management, and propositions of practical recommendations. Haemophilia. 2022, 28:938-49. 10.1111\/hae.14648","journal-title":"Haemophilia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2088.x","article-title":"Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells","volume":"96","author":"Tefferi A","year":"1997","unstructured":"Tefferi A, Hanson CA, Kurtin PJ, Katzmann JA, Dalton RJ, Nichols WL. Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells. Br J Haematol. 1997, 96:850-3. 10.1046\/j.1365-2141.1997.d01-2088.x","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.52.210","article-title":"Successful treatment with rituximab in a patient with primary thymic MALT lymphoma complicated with acquired von Willebrand syndrome and Sj\u00f6gren syndrome (Article in Japanese)","volume":"52","author":"Iwabuchi T","year":"2011","unstructured":"Iwabuchi T, Kimura Y, Suzuki T, et al.. Successful treatment with rituximab in a patient with primary thymic MALT lymphoma complicated with acquired von Willebrand syndrome and Sj\u00f6gren syndrome (Article in Japanese). Rinsho Ketsueki. 2011, 52:210-5. 10.11406\/rinketsu.52.210","journal-title":"Rinsho Ketsueki"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.59.420","article-title":"Durable remission attained with rituximab therapy in a patient with acquired von Willebrand syndrome associated with CD20-positive lymphoproliferative disorder (Article in Japanese)","volume":"59","author":"Kurahashi H","year":"2018","unstructured":"Kurahashi H, Kawabata Y, Michishita Y, Kitabayashi A, Kobayashi T, Kitadate A, Takahashi N. Durable remission attained with rituximab therapy in a patient with acquired von Willebrand syndrome associated with CD20-positive lymphoproliferative disorder (Article in Japanese). Rinsho Ketsueki. 2018, 59:420-5. 10.11406\/rinketsu.59.420","journal-title":"Rinsho Ketsueki"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson BD","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, et al.. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014, 32:3059-68. 10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede A","year":"2011","unstructured":"Tiede A, Rand JH, Budde U, Ganser A, Federici AB. How I treat the acquired von Willebrand syndrome. Blood. 2011, 117:6777-85. 10.1182\/blood-2010-11-297580","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10298","article-title":"Acquired von Willebrand's syndrome: a single institution experience","volume":"72","author":"Kumar S","year":"2003","unstructured":"Kumar S, Pruthi RK, Nichols WL. Acquired von Willebrand's syndrome: a single institution experience. Am J Hematol. 2003, 72:243-7. 10.1002\/ajh.10298","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7258","article-title":"Splenic marginal zone lymphoma with acquired von Willebrand syndrome diagnosed via splenic bleeding","volume":"56","author":"Komeno Y","year":"2017","unstructured":"Komeno Y, Shibuya N, Uryu H, et al.. Splenic marginal zone lymphoma with acquired von Willebrand syndrome diagnosed via splenic bleeding. Intern Med. 2017, 56:557-62. 10.2169\/internalmedicine.56.7258","journal-title":"Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02681.x","article-title":"Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma","volume":"18","author":"Biondo F","year":"2012","unstructured":"Biondo F, Matturro A, Santoro C, et al.. Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma. Haemophilia. 2012, 18:e34-5. 10.1111\/j.1365-2516.2011.02681.x","journal-title":"Haemophilia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9815-22","article-title":"Acquired von Willebrand syndrome in a patient with multiple comorbidities, including MALT lymphoma with IgA monoclonal gammopathy and hyperviscosity syndrome","volume":"62","author":"Owari M","year":"2023","unstructured":"Owari M, Harada-Shirado K, Togawa R, et al.. Acquired von Willebrand syndrome in a patient with multiple comorbidities, including MALT lymphoma with IgA monoclonal gammopathy and hyperviscosity syndrome. Intern Med. 2023, 62:605-11. 10.2169\/internalmedicine.9815-22","journal-title":"Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13243","article-title":"Acquired von Willebrand syndrome in haematologic malignancies - how the clinical-laboratory correlation improves a challenging diagnosis - a case series","volume":"23","author":"Fidalgo T","year":"2017","unstructured":"Fidalgo T, Ferreira G, Oliveira AC, et al.. Acquired von Willebrand syndrome in haematologic malignancies - how the clinical-laboratory correlation improves a challenging diagnosis - a case series. Haemophilia. 2017, 23:e361-5. 10.1111\/hae.13243","journal-title":"Haemophilia"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.486","article-title":"Lymphoma-associated acquired von Willebrand syndrome responsive to splenectomy: a case report","volume":"3","author":"Khadadah F","year":"2022","unstructured":"Khadadah F, Rupani N, Scott J, Trinkaus M, Teitel J, Sholzberg M. Lymphoma-associated acquired von Willebrand syndrome responsive to splenectomy: a case report. EJHaem. 2022, 3:996-9. 10.1002\/jha2.486","journal-title":"EJHaem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0141","article-title":"Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management","volume":"14","author":"Michiels JJ","year":"2001","unstructured":"Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol. 2001, 14:401-36. 10.1053\/beha.2001.0141","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-024-03861-6","article-title":"Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance","volume":"121","author":"Okamoto S","year":"2025","unstructured":"Okamoto S, Suzuki A, Tamura S, et al.. Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance. Int J Hematol. 2025, 121:131-6. 10.1007\/s12185-024-03861-6","journal-title":"Int J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/401638-successful-treatment-of-acquired-von-willebrand-syndrome-in-a-rare-case-of-nodal-marginal-zone-lymphoma-with-rituximab-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:53:51Z","timestamp":1756371231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/401638-successful-treatment-of-acquired-von-willebrand-syndrome-in-a-rare-case-of-nodal-marginal-zone-lymphoma-with-rituximab-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.91158","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}